chr4-68945371-G-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_024743.4(UGT2A3):āc.799C>Gā(p.Pro267Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000869 in 1,611,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 31)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
UGT2A3
NM_024743.4 missense
NM_024743.4 missense
Scores
3
8
7
Clinical Significance
Conservation
PhyloP100: 5.87
Genes affected
UGT2A3 (HGNC:28528): (UDP glucuronosyltransferase family 2 member A3) Enables glucuronosyltransferase activity. Involved in cellular glucuronidation. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.974
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2A3 | NM_024743.4 | c.799C>G | p.Pro267Ala | missense_variant | 2/6 | ENST00000251566.9 | NP_079019.3 | |
UGT2A3 | XM_011532247.3 | c.799C>G | p.Pro267Ala | missense_variant | 2/6 | XP_011530549.1 | ||
UGT2A3 | XM_047416177.1 | c.-69C>G | 5_prime_UTR_variant | 2/6 | XP_047272133.1 | |||
UGT2A3 | NR_024010.2 | n.843C>G | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT2A3 | ENST00000251566.9 | c.799C>G | p.Pro267Ala | missense_variant | 2/6 | 1 | NM_024743.4 | ENSP00000251566 | P1 | |
UGT2A3 | ENST00000503012.1 | c.397C>G | p.Pro133Ala | missense_variant, NMD_transcript_variant | 2/7 | 2 | ENSP00000424092 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151618Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151618
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249138Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134668
GnomAD3 exomes
AF:
AC:
1
AN:
249138
Hom.:
AF XY:
AC XY:
1
AN XY:
134668
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1459666Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726174
GnomAD4 exome
AF:
AC:
13
AN:
1459666
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
726174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151618Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74012
GnomAD4 genome
AF:
AC:
1
AN:
151618
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74012
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.799C>G (p.P267A) alteration is located in exon 2 (coding exon 2) of the UGT2A3 gene. This alteration results from a C to G substitution at nucleotide position 799, causing the proline (P) at amino acid position 267 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at P267 (P = 0.1257);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at